Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.

Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.
复制标题

DOI:
10.1016/j.bmcl.2011.01.079
复制
发表时间:
2011-03-15
影响因子:
2.7
通讯作者:
LoGrasso PV
LoGrasso PV
中科院分区:
医学4区
文献类型:
--
作者:
He Y;Kamenecka TM;Shin Y;Song X;Jiang R;Noel R;Duckett D;Chen W;Ling YY;Cameron MD;Lin L;Khan S;Koenig M;LoGrasso PV

文献摘要

参考文献

被引文献

相似文献

喹唑啉3是一种新型的c-jun N-末端激酶(JNK)抑制剂,具有良好的脑渗透性和药代动力学(PK)特性。发现了许多在生物化学和细胞测定中均有效的类似物。喹唑啉13 a被发现是一种有效的JNK 3抑制剂(IC 50 =40 nM),具有超过p38的>500倍的选择性,并且具有良好的PK和脑渗透特性。由于这些性质,13 a被认为是体内评价的潜在候选物。
Quinazoline 3 was discovered as a novel c-jun N-terminal kinase (JNK) inhibitor with good brain penetration and pharmacokinetic (PK) properties. A number of analogs which were potent both in the biochemical and cellular assays were discovered. Quinazoline 13a was found to be a potent JNK3 inhibitor (IC50=40 nM), with >500-fold selectivity over p38, and had good PK and brain penetration properties. With these properties, 13a is considered a potential candidate for in vivo evaluation.
DOI: 10.1124/jpet.103.064246
发表时间: 2004-07-01
影响因子: 3.5
作者:
Carboni, S;Hiver, A;Vitte, PA
通讯作者: Vitte, PA
DOI: 10.1038/sj.bjp.0707574
发表时间: 2008-01-01
影响因子: 7.3
作者:
Carboni, S.;Boschert, U.;Vitte, P-A
通讯作者: Vitte, P-A
DOI: 10.1016/j.bmcl.2009.03.023
发表时间: 2009-04-15
影响因子: 2.7
作者:
Humphries, Paul S.;Lafontaine, Jennifer A.;Wilhite, David M.
通讯作者: Wilhite, David M.
DOI: 10.1021/jm060199b
发表时间: 2006-06-15
影响因子: 7.3
作者:
Szczepankiewicz, Bruce G.;Kosogof, Christi;Trevillyan, James M.
通讯作者: Trevillyan, James M.
DOI: 10.1021/jm0310986
发表时间: 2005-07-14
影响因子: 7.3
作者:
Gaillard, P;Jeanclaude-Etter, I;Gotteland, JP
通讯作者: Gotteland, JP